Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Hepatocellular Carcinoma”

657 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 657 results

Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01271504
What this trial is testing

E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Inc. 102
Testing effectiveness (Phase 2)Study completedNCT01639352
What this trial is testing

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Lynn Feun 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Testing effectiveness (Phase 2)UnknownNCT03839550
What this trial is testing

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Study completedNCT03753659
What this trial is testing

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 30
Testing effectiveness (Phase 2)Study completedNCT01004003
What this trial is testing

Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 125
Testing effectiveness (Phase 2)Looking for participantsNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06389422
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)WithdrawnNCT03746249
What this trial is testing

Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Ended earlyNCT04212221
What this trial is testing

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 89
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)Looking for participantsNCT03755739
What this trial is testing

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Who this might be right for
HepatocarcinomaLung CancerMelanoma+7 more
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Study completedNCT02981498
What this trial is testing

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT00610389
What this trial is testing

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaCarcinoma, Hepatocellular
Clinica Universidad de Navarra, Universidad de Navarra 27
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Load More Results